Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:46 pm Purchase |
2023-12-31 | 13G | NeuBase Therapeutics, Inc. NBSE |
GREENLIGHT CAPITAL INC | 136,350 3.700% |
136,350 (New Position) |
Filing History |
| 2023-09-20 5:28 pm Sale |
2023-09-14 | 13D | NeuBase Therapeutics, Inc. NBSE |
Symetryx Corp | 109,508 3.500% |
-363,418 (-76.84%) |
Filing History |
| 2023-09-14 06:03 am Purchase |
2023-09-08 | 13D | NeuBase Therapeutics, Inc. NBSE |
Symetryx Corp | 472,926 9.100% |
44,482 (+10.38%) |
Filing History |
| 2023-08-31 11:50 am Purchase |
2023-08-22 | 13D | NeuBase Therapeutics, Inc. NBSE |
Symetryx Corp | 428,444 13.800% |
428,444 (New Position) |
Filing History |
| 2023-01-27 12:49 pm Purchase |
2022-12-29 | 13G | NeuBase Therapeutics, Inc. NBSE |
Kershner Trading Americas LLC | 74,861 4.460% |
74,861 (New Position) |
Filing History |
| 2022-02-14 3:32 pm Purchase |
2021-12-31 | 13G | NeuBase Therapeutics, Inc. NBSE |
GREENLIGHT CAPITAL INC | 136,351 8.300% |
35,000 (+34.53%) |
Filing History |
| 2021-02-16 3:40 pm Purchase |
2021-02-16 | 13G | NeuBase Therapeutics, Inc. NBSE |
GREENLIGHT CAPITAL INC | 101,351 8.700% |
24,428 (+31.76%) |
Filing History |
| 2020-12-29 12:14 pm Purchase |
2020-12-04 | 13G | NeuBase Therapeutics, Inc. NBSE |
Kershner Trading Americas LLC | 66,950 1.000% |
66,950 (New Position) |
Filing History |
| 2020-05-01 4:17 pm Purchase |
2019-07-12 | 13G | NeuBase Therapeutics, Inc. NBSE |
HIRSCHMAN ORIN | 28,199 2.440% |
28,199 (New Position) |
Filing History |